{
    "Trade/Device Name(s)": [
        "Elecsys Anti-HAV II",
        "PreciControl Anti-HAV II"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K190428",
    "Predicate Device Reference 510(k) Number(s)": [
        "K100903"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LOL",
        "QCH"
    ],
    "Summary Letter Date": "February 20, 2019",
    "Summary Letter Received Date": "February 22, 2019",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3310",
        "21 CFR 866.3920"
    ],
    "Regulation Name(s)": [
        "Hepatitis A Virus (HAV) Serological Assays",
        "Quality Control Material for Clinical Microbiology Assays"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "serology"
    ],
    "Analyte(s)": [
        "Total antibodies to hepatitis A virus (HAV)",
        "IgG",
        "IgM"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Li-Heparin tube",
        "Potassium EDTA tube",
        "Na-Citrate tube",
        "Na-Heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "cobas e 601 immunoassay analyzer",
        "cobas e immunoassay analyzers"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemiluminescence immunoassay (ECLIA)",
        "Competition principle"
    ],
    "Methodologies": [
        "Qualitative antibody detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Elecsys Anti-HAV II qualitative electrochemiluminescence immunoassay for detection of total HAV antibodies using cobas e analyzers",
    "Indications for Use Summary": "Aid in the clinical laboratory diagnosis of acute or past hepatitis A virus infection, and to determine antibody response to HAV in vaccine recipients, for use on cobas e immunoassay analyzers with serum or plasma from pediatric (2\u201321 years) and adult patients",
    "fda_folder": "Microbiology"
}